Who we are

Suzzy Bhavekar is a highly skilled professional with over ten years of experience in leading study design, execution, and interpretation within the CRO and pharmaceutical industries. Her expertise covers the full lifecycle of drug development, bringing a crucial level of scientific judgment to teams. With an active pharmacist license, she possesses a unique understanding of drug behavior, safety, quality, and regulatory expectations, enabling her to guide programs with a comprehensive view of how laboratory decisions impact development, approval, and real-world outcomes. Suzzy excels in designing studies from concept, building robust scientific roadmaps, and connecting bench data to critical clinical and operational decisions, ensuring clarity and direction for all stakeholders. She delivers the scientific depth, operational leadership, and holistic understanding required to drive pharmaceutical programs to successful completion.

Scott Bailey is a highly skilled analytical and bioanalytical professional with over two decades of experience in strengthening laboratory operations within the pharmaceutical, biotechnology, and CDMO/CRO sectors. His technical expertise spans chromatography, bioanalytical assays, and method development, enabling him to design robust analytical methods and ensure compliance with rigorous quality standards. Scott excels in validating and transferring analytical methods, supporting stability testing, and developing comprehensive documentation systems. With a strong focus on scientific principles, he delivers the technical depth and accuracy needed to advance your laboratory's capabilities while meeting regulatory requirements efficiently. His deep technical acumen ensures the reliability of analytical results, directly supporting critical regulatory submissions and product lifecycle management.

Ryan Carney is a highly skilled professional with extensive experience in establishing and strengthening quality and compliance systems for pharmaceutical, biotechnology, and CDMO/CRO organizations. His technical expertise spans robust analytical method development and validation, meticulous sample analysis under stringent regulatory guidelines (GMP/GLP), and comprehensive data and batch record reviews. He is proficient in optimizing LIMS and analytical software, and managing critical quality processes like change controls, deviations, CAPA, and investigations. Ryan excels in guiding biotech companies through preclinical testing and critical regulatory submissions (e.g., Pre-IDE, IDE, 510(k)), ensuring scientific integrity and operational excellence. With a strong focus on scientific principles and regulatory rigor, he delivers the technical depth and operational clarity needed to elevate your laboratory's performance and ensure unwavering compliance within the biotech landscape.

Sherwin is a hands on Principal Scientist with deep roots in analytical chemistry and bioanalysis. With advanced training in chemistry and decades of laboratory experience, he brings both scientific depth and practical execution to every project. He is not just a strategic leader, but an active laboratory scientist who understands the chemistry behind the methods, instruments, and data.

As a subject matter expert in small and large molecule bioanalysis, Sherwin has led complex LC MS MS method development, optimization, and validation programs under GLP and global regulatory standards. He has successfully built and strengthened bioanalytical laboratories, guided preclinical and clinical assay strategies, and overseen challenging multi analyte validations with precision and scientific rigor. What sets Sherwin apart is his ability to bridge theory and practice. He understands molecular behavior, chromatographic separation, mass spectrometric detection, and regulatory expectations at a detailed level, allowing him to troubleshoot effectively and design robust, reliable methods.